ZW4285A1 - Dopamine-beta-hydroxylase inhibitors - Google Patents

Dopamine-beta-hydroxylase inhibitors

Info

Publication number
ZW4285A1
ZW4285A1 ZW42/85A ZW4285A ZW4285A1 ZW 4285 A1 ZW4285 A1 ZW 4285A1 ZW 42/85 A ZW42/85 A ZW 42/85A ZW 4285 A ZW4285 A ZW 4285A ZW 4285 A1 ZW4285 A1 ZW 4285A1
Authority
ZW
Zimbabwe
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
ZW42/85A
Other languages
English (en)
Inventor
Simpson Frazee James
Kaiser Carl
Ivan Kruse Lawrence
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZW4285A1 publication Critical patent/ZW4285A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZW42/85A 1984-03-19 1985-03-12 Dopamine-beta-hydroxylase inhibitors ZW4285A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59066584A 1984-03-19 1984-03-19

Publications (1)

Publication Number Publication Date
ZW4285A1 true ZW4285A1 (en) 1985-06-26

Family

ID=24363168

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW42/85A ZW4285A1 (en) 1984-03-19 1985-03-12 Dopamine-beta-hydroxylase inhibitors

Country Status (9)

Country Link
KR (1) KR850006189A (da)
DK (2) DK118985A (da)
FI (1) FI83309C (da)
HU (1) HU194184B (da)
IL (1) IL74586A (da)
NO (1) NO162616C (da)
NZ (2) NZ211440A (da)
PH (1) PH21032A (da)
ZW (1) ZW4285A1 (da)

Also Published As

Publication number Publication date
IL74586A (en) 1988-11-30
DK118985D0 (da) 1985-03-15
FI83309B (fi) 1991-03-15
IL74586A0 (en) 1985-06-30
HU194184B (en) 1988-01-28
NZ211440A (en) 1988-09-29
FI851073L (fi) 1985-09-20
NO162616C (no) 1990-01-24
DK189691A (da) 1991-11-20
NO851056L (no) 1985-09-20
FI83309C (fi) 1991-06-25
DK189691D0 (da) 1991-11-20
PH21032A (en) 1987-06-30
FI851073A0 (fi) 1985-03-18
DK118985A (da) 1985-09-20
NZ222876A (en) 1988-09-29
NO162616B (no) 1989-10-16
HUT37602A (en) 1986-01-23
KR850006189A (ko) 1985-10-02

Similar Documents

Publication Publication Date Title
PT78388A (en) Dopamine-beta-hydroxylase inhibitors
PL256327A1 (en) Holding handage
ZA884838B (en) Dopamine-beta-hydroxylase inhibitors
ZA883851B (en) Dopamine-beta-hydroxylase inhibitors
ZA865775B (en) Dopamine-beta-hydroxylase inhibitors
PT85081A (en) Irreversible dopamine-beta-hydroxylase inhibitors
PT83628A (en) Dopamine-beta-hydroxylase inhibitors
ZA889667B (en) Dopamine-beta-hydroxylase inhibitors
ZA889709B (en) Dopamine-beta-hydroxylase inhibitors
PT85596B (en) Dopamine-beta-hydroxylase inhibitors
PT84904B (en) Dopamine-beta-hydroxylase inhibitors
ZA882100B (en) Dopamine-beta-hydroxylase inhibitors
PT86513A (en) Dopamine-beta-hydroxylase inhibitors
ZA868234B (en) Dopamine-beta-hydroxylase inhibitors
AU590538B2 (en) Dopamine-beta-hydroxylase inhibitors
GB8500713D0 (en) Swab
ZA842962B (en) Dopamine-beta-hydroxylase inhibitors
ZA842963B (en) Dopamine-beta-hydroxylase inhibitors
ZA882275B (en) Dopamine-beta-hydroxylase inhibitors
DE3477926D1 (en) Dopamine-beta-hydroxylase inhibitors
EP0175291A3 (en) Novel alpha-d-mannosidase inhibitor
GB8412295D0 (en) Pipes
IL74586A0 (en) Dopamine-beta-hydroxylase inhibiting phenylalkylimidazole derivatives
GB8424623D0 (en) Swabs
IE842780L (en) 5-lipoxygenase inhibitors